Serum cold agglutinin and IgM levels in breast carcinoma

Volker E. Dube*, Max Haid, Joan Sander Chmiel, Byron Anderson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Breast carcinoma (BCa) cells produce I antigen or I antigen-like substances that may influence serum anti-I. We determined cold hemagglutinins in 170 BCa patients, 97 women with benign breast disease, and 37 female controls of comparable ages to the patients. The results were expressed as an anti-I score. Serum IgM was measured by radial immunodiffusion. The data for the BCa patients were analyzed by pathologic stage (PS) and histologic category. The anti-I score for PS III (28.1 ± 13.0; mean ± S.D.) was higher (p<0.02), and that for PS IV (11.4 ± 7.4) lower (p<0.02) than the control value (17.7 ± 10.2). IgM concentrations of the BCa patients as a group or by PS were similar to those of the controls. The mean anti-I scores were higher in mucinous (31.1 ± 14.9, p<0.001) and apocrine BCa (28.6 ± 16.2, p<0.02) compared to the control value. IgM concentrations were elevated in mucinous (218.1 ± 85.8 mg/dl, p<0.01) and apocrine BCa (241.9 ± 99.0, p<0.005) compared to the control value (157.1 ± 66.9). The results suggest an association of anti-I scores and PS of BCa and suggest an antigenic difference of mucinous and apocrine from infiltrative ductal BCa.

Original languageEnglish (US)
Pages (from-to)105-108
Number of pages4
JournalBreast Cancer Research and Treatment
Issue number2
StatePublished - Jun 1 1984


  • IgM
  • auto anti-I
  • breast carcinoma
  • immune response

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Serum cold agglutinin and IgM levels in breast carcinoma'. Together they form a unique fingerprint.

Cite this